Navigation Links
Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
Date:6/10/2008

William Bailey, M.D., lead author and Director of the Lung Health Center at the University of Alabama at Birmingham. "Preventing exacerbations and improving lung function are important goals of asthma management."

Current treatment guidelines recommend the addition of a LABA to an ICS in patients with moderate to severe asthma who are uncontrolled on an ICS alone. Taken in combination, an ICS and LABA fight the two main components of asthma -- inflammation (swelling in the airways) and airway constriction (the tightening of muscles that surround the airways). Inhaled corticosteroids treat the inflammation, while LABAs treat the airway constriction. Optimal therapy for many patients with persistent moderate to severe asthma requires treatment of both these components.

The study was designed to primarily show that Advair improved the rate of exacerbations compared to Flovent. While Advair patients had a lower exacerbation rate than those patients in the Flovent group, the difference was not statistically significant. On most of the secondary endpoints, patients given Advair performed better than patients who used Flovent. Forced expiratory volume in one second (FEV1) improved in Advair patients. Both morning and evening peak expiratory flow (PEF) were also improved in the Advair group. Patients using Advair were also less likely to awake at night due to asthma-related breathing difficulties. Additionally, the Advair group showed reductions in the rate of daily symptoms and the need for a rescue inhaler.

Both Advair and Flovent were well tolerated. Over a one-year period, the overall incidence of adverse events was similar between the two groups.

Important Information about Advair Diskus

Advair Diskus won't replace fast-acting inhalers for sudden symptoms and should not be taken more than twice a day. Advair Diskus contains salmeterol. In patients with asthma, medicines like salmeterol may increase the chance of asthma-related death.
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
(Date:8/28/2015)... Aug. 28, 2015 Perrigo Company plc ("Perrigo") ... Mylan N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote ... "Our views of Mylan,s offer to Perrigo shareholders ... on our Board,s careful reflection of the value available ... limited choices that Mylan has allowed its shareholders to ...
(Date:8/28/2015)... The report "Eubiotics Market by Type (Probiotics, Prebiotics, ... Aquaculture), & by Region ( North America , ... and Rest of the World) - Global Trends and Forecast ... was valued at USD 4.62 Billion in 2014 and is ... CAGR of 7.4% from 2015 to 2020. ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... 2007 - Cytogen,Corporation (NASDAQ: CYTO) reported updated ... evaluating QUADRAMET(R) (samarium Sm-153,lexidronam injection) in combination ... with relapsed,multiple myeloma. Data from 33 patients ... 1 Trial of Bortezomib (Vel) and Samarium,(Sam) ...
... achieved with VELCADE, lenalidomide,and dexamethasone , ,KOS, ... (Nasdaq: MLNM) today reported on the,presentation of ... based,therapies that showed consistently high survival and ... newly diagnosed,multiple myeloma (MM) patients. These data ...
Cached Medicine Technology:Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8
(Date:8/31/2015)... ... , ... On Saturday, July 11, 2015, during the annual New York State ... was proud to recognize Dr. Merritt F. Spear as the 2015 recipient of the ... long-time NYSATA member and Ithaca College athletic trainer and educator, is considered for individuals ...
(Date:8/31/2015)... ... ... Adult & Pediatric Dermatology in Greenwood Village, CO has launched a new ... services available to help them. , The website better showcases the practice to ... to view the website seamlessly on any desktop computer, tablet or mobile device. , ...
(Date:8/31/2015)... ... ... The Marietta dentists and staff at Verde Pointe Dental Associates ... staff ran a 5K race, the Iron Horse for Enduring Hearts on August 30th, ... the event to help support projects with funding to increase understanding of clinical and ...
(Date:8/30/2015)... ... 31, 2015 , ... Negotiating an FDA Import Hold Crisis:, Strategies for Challenging ... http://www.fdanews.com/importholdcrisis , US authorities are holding imports more than ever before, particularly ... With alerts on an uptick and a new final rule, having a top-notch import ...
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... across platforms and devices, today announced it is a Silver Sponsor of the ... at Sky City Convention Centre in Auckland, NZ. Throughout the event, AvePoint will ...
Breaking Medicine News(10 mins):Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 2Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 3Health News:Verde Pointe Dental Associates Runs a 5K for Enduring Hearts 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4
... test is all it could take to tell if you ... team of international scientists have discovered more than 10 types ... of a person who recently suffered a stroke or heart ... international collaboration led by Nanyang Technological University (NTU),s lead scientist, ...
... Virginia G. Piper Cancer Center Clinical Trials are the first ... determine the safety, tolerability and preliminary activity of an investigational ... form of lung cancer, as well as other forms of ... patient on the study was administered the first dose of ...
... in infant death are significantly more likely to have ... September) in BJOG: An International Journal of Obstetrics ... rates of stillbirth in subsequent pregnancy, the study by ... the University of Rochester found. Infant mortality ...
... News) -- People who are depressed are at greater risk ... researchers pointed out that the findings could have a significant ... of death and permanent disability. Researchers analyzed 28 previous ... 8,478 stroke cases. The investigators found that depression was associated ...
... Scientists proposing to develop vaccines against methamphetamine and nicotine ... for Innovative Medication Development Research. The two scientists, ... and Dr. Peter Burkhard, of the University of Connecticut, ... years to support their research, according to the National ...
... , TUESDAY, Sept. 20 (HealthDay News) -- Black women who develop ... second cancer in the other breast, and those who are diagnosed ... cancer of a more aggressive form, new research indicates. ... to be more aggressive, more likely to be estrogen-receptor negative and ...
Cached Medicine News:Health News:Novel research set to pinpoint risk of heart attacks and strokes 2Health News:Novel research set to pinpoint risk of heart attacks and strokes 3Health News:TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer 2Health News:Infant mortality linked to subsequent risk of stillbirth finds new US study 2Health News:Infant mortality linked to subsequent risk of stillbirth finds new US study 3Health News:Depression Tied to Higher Risk for Stroke 2Health News:NIDA Avant-Garde-Medications Development Award winners announced 2Health News:Higher Risk of Second Breast Cancer Seen in Black Women 2
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
2 mm tip....
4 mm x 6 mm dissector end with shaft marked at 10 mm, 20 mm, 30 mm from tip. 6 mm wide curved elevator. Round knurled handle....
Medicine Products: